Cargando…
Anastrozole-induced pulmonary cryptococcosis in a patient with early breast cancer: A case report
INTRODUCTION: Estrogen is a key factor in breast cancer carcinogenesis, and reductions in its synthesis can decrease breast cancer risk. Anastrozole can reduce plasma estrogen levels by inhibiting the enzyme aromatase, and is approved for adjuvant treatment of breast cancer. We report a case of pulm...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959891/ https://www.ncbi.nlm.nih.gov/pubmed/31914067 http://dx.doi.org/10.1097/MD.0000000000018688 |